Analyst picks & changes
(CTRX)
Oppenheimer & Co. analyst Jeffrey Casdin rated CTRX a "buy" and added it to OpCo's "Recommended List." When CTRX was spun off
Gathering data...
Products & Solutions
About Biocentury
Contact
Privacy & Legal
- Follow Us
Gathering data...
(CTRX)
Oppenheimer & Co. analyst Jeffrey Casdin rated CTRX a "buy" and added it to OpCo's "Recommended List." When CTRX was spun off